Aclaris Therapeutics to Announce Third Quarter 2016 Financial Results on November 3, 2016

MALVERN, Pa., Oct. 25, 2016 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, will release its third quarter financial results before the market opens on Thursday, November 3, 2016.

Management will conduct a conference call at 8:30 a.m. ET that day to discuss the Company’s financial results and provide a general business update.  The conference will be webcast live over the Internet and can be accessed by logging on to the “Investors” section of the Aclaris Therapeutics website, www.aclaristx.com, prior to the event.  A replay of the webcast will be archived on the Company’s website for 30 days following the call.

To participate on the live call, please dial (844) 776-7782 (domestic) or (661) 378-9535 (international), and reference conference ID 97609147 prior to the start of the call. 

About Aclaris

Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology.  Aclaris Therapeutics, Inc. is based in Malvern, Pennsylvania and more information can be found by visiting the company’s website at www.aclaristx.com.

Contact:

Aclaris Contact
Michael Tung, M.D. 
Investor Relations
484-329-2140
[email protected]

Media Contact
Mariann Caprino
TogoRun
917-242-1087
[email protected]